Roni Shye - September 19, 2018
If you’re having trouble affording your insulin, you’re not alone. Research has shown that expenses for diabetes can reach well beyond $1,000 a month, leaving many who cannot afford this cost without care.
In response to the ever-climbing prices of insulin, manufacturer Eli Lilly created the Lilly Diabetes Solution Center, a helpline aimed at finding personalized solutions for uninsured and low-income individuals who need help paying for their insulin. See More
Benita Lee - September 05, 2018
Despite outrage over the high cost of insulin, prices for popular insulin treatments have continued to climb in 2018, according to a GoodRx analysis of drug prices.
Though prices are not climbing as quickly as they did between 2002 and 2013—when the average cost of insulin therapy tripled—the average price of insulin has increased by 64% since January 2014. Since the beginning of 2017, when drug prices became a key part of White House agenda, insulin prices have increased by 9% on average. See More
Dr. Sharon Orrange - August 21, 2018
Cutting down or rationing insulin has dire consequences for all type 1 as well as type 2 diabetics dependent on insulin. Working in a busy practice alongside an endocrinologist with predominantly type 1 diabetic patients, I’ve seen the team behind our doctors working hard to keep insulin affordable for patients. Here is what I’ve learned from the best.
Steps for insured patients
If you’re about to take insulin, choose one that’s preferred:
- Call your insurance first to find their preferred insulin products. See More
Roni Shye - April 10, 2018
Long-acting insulins are only administered once or twice daily, and include drugs like Lantus, Toujeo, Basaglar, and Levemir. As of March 27th, we have a new one to add to the long-acting insulin family – Toujeo Max SoloStar.
What is Toujeo Max SoloStar indicated for?
Toujeo Max SoloStar is indicated to improve blood sugar control in adults with diabetes. It will be available in a 3 ml disposable prefilled SoloStar pen in the strength of 300 units/ml. See More
Tori Marsh - January 17, 2018
Humalog (insulin lispro) is a fast-acting insulin used to treat diabetes type one and two. Doctors report low levels of adherence to insulins like Humalog because of its cost. Cash prices for Humalog average around $549 for five kwikpens, and there is no generic alternative for any insulin rbrand. Humalog generated billions of dollars in global sales for Eli Lilly in 2016.
Here is some information on Humalog, and how you can save. See More
Tori Marsh - December 22, 2017
One of the only ways to treat diabetes type 1 and 2 are through insulin injections, like Lantus (insulin glargine), that help to control blood sugar. Unfortunately, doctors consistently report low levels of adherence to insulins, Lantus included. The main reason? The cost.
Lantus is a prime example of an expensive insulin—averaging around $274 per month, it is unaffordable for many. But GoodRx is here to help.
Here is some information on Lantus, and how you can save
Why are insulins, and Lantus, so expensive?
The case of insulin prices is an interesting one. See More
Roni Shye - November 21, 2017
For people who need to take insulin, there are a couple of different types—long-acting, short-acting, rapid-acting, intermediate-acting, etc. That’s a lot of options!
One question I see most often is the difference between rapid-acting and long-acting insulins. So, let’s get into it.
What is rapid-acting insulin?
Rapid-acting, or meal-time insulin, is a type of insulin that’s usually taken before, during, or after a meal to lower your blood sugar levels associated with meals. See More
Roni Shye - July 28, 2017
If you have type 2 diabetes, your doctor or health care provider has most likely prescribed you a long acting insulin like Lantus (insulin glargine), Toujeo (insulin glargine), or Basaglar (insulin glargine). These type of insulins work to control your blood sugar between meals and when you’re sleeping. They can be injected once or twice a day to give you around-the-clock blood sugar control.
Dr. Sharon Orrange - June 07, 2016
Insulin: legal, widely used, and transforms lives. But there are risks—soon you’ll see why we try to spare our type II diabetics from having to start insulin. Using oral medications to their maximum dose and incorporating diet and lifestyle changes is the way to go before resorting to insulin.
Of course, tight blood sugar control is the goal for reducing diabetes related complications (kidney disease, eye disease, neuropathy) but insulin remains one of the most challenging aspects of diabetes management given the risks. See More
Roni Shye - February 17, 2016
Basaglar (insulin glargine) is the newest brand of long-acting insulin to hit the market. It shares its active ingredient (insulin glargine) with Lantus, but is not a generic equivalent and the two can’t be substituted for each other.
Long-acting insulin like Basaglar (also sometimes referred to as basal insulin) are used to keep blood glucose levels stable throughout the day.